trusted by 100+ Patients

AOD-9604

Support Fat Loss & Metabolic Health with AOD-9604 Peptide

About the Treatment

What Is AOD-9604?

AOD-9604 is a lab-developed peptide created from a small part of the human growth hormone. Scientists designed it to focus solely on the fat-burning effects of growth hormone, without triggering the growth or hormonal changes associated with full HGH.

Instead of affecting growth hormone levels or blood sugar, AOD-9604 works directly on fat tissue. Early research and animal studies suggest it may help the body break down stored fat, reduce new fat storage, and support healthier body composition. Because of this targeted action, AOD-9604 has attracted attention in peptide research on weight management and metabolic health.

Key Benefits

AOD-9604 Benefits

🔥

Supports Fat Metabolism

Encourages fat breakdown by increasing lipolysis in fat cells and supporting fat oxidation.
🎯

Targets Stubborn Fat

Often explored for areas resistant to diet and exercise, supporting fat loss without hormonal overstimulation.
⚙️

Supports Metabolic Health

Designed to influence metabolic pathways involved in energy balance and metabolic efficiency.
🚫

Does Not Raise Growth Hormone or IGF-1 Levels

Unlike full growth hormone therapy, AOD-9604 does not significantly stimulate IGF-1 or systemic growth pathways.
⚖️

Non-Hormonal Weight Management Support

Positioned as a peptide-based approach to assist weight loss journeys alongside diet, exercise plans, and lifestyle changes.

Advanced diagnostics. Regenerative therapies. Personalised wellness plans.

Advanced diagnostics. Regenerative therapies. Personalised wellness plans.

FAQs

01

What exactly is AOD-9604?

AOD-9604 is a synthetic peptide, also referred to as a growth hormone fragment or GH fragment, derived from the C-terminus of the human growth hormone molecule. It represents a synthetic lipolytic domain designed to influence fat metabolism without triggering growth-related effects.
02

Is AOD-9604 FDA-approved?

AOD-9604 is not FDA-approved for weight loss or fat-burning claims. Its regulatory status classifies it as a research peptide. While early studies and animal studies exist, large-scale human trials remain limited.
03

How does AOD-9604 support fat loss?

Studies suggest AOD-9604 increases lipolysis by acting on fat cells within adipose tissue. It promotes fat oxidation, reduces fat mass, and limits fat accumulation by influencing metabolic pathways involved in fat metabolism.
04

Does AOD-9604 affect blood sugar or insulin resistance?

Clinical data indicate that AOD-9604 has minimal effects on blood glucose, blood sugar, insulin resistance, or blood pressure compared with full growth hormone therapy. This makes it metabolically distinct from traditional growth hormone treatments.
05

Can AOD-9604 help me lose weight?

Some animal studies suggest that AOD‑9604 may limit the formation of new fat cells, a process known as lipogenesis. Most human studies of AOD 9604 lasted only 12–24 weeks, leaving long-term effects unknown.
06

How is AOD-9604 typically administered?

Most protocols involve subcutaneous injection. AOD-9604 is typically run in cycles of 4 to 12 weeks, depending on individual body composition goals. Taking breaks of 2 to 4 weeks between AOD-9604 cycles may help maintain sensitivity and responsiveness.
07

Is AOD-9604 considered peptide therapy?

Yes. AOD-9604 falls under peptide therapy and metabolic pharmaceuticals being researched for fat metabolism and body composition support. AOD-9604 can be stacked with other peptides like CJC-1295 and Ipamorelin to potentially enhance fat-loss effects.
08

Is AOD-9604 banned in professional sports?

Yes. AOD-9604 is listed by the World Anti-Doping Agency, and competitive athletes should avoid its use.
09

What does clinical evidence say about safety?

Clinical studies on AOD-9604 indicate that the peptide is generally well-tolerated. No significant adverse effects were reported in human trials at doses up to 1 mg/day.